Abstract

Proto Labs will release its second-quarter 2026 results on July 31, 2026 Pre-MKt; this preview compiles market forecasts, last quarter performance, and institutional views to frame what investors should watch.

Market Forecast

Consensus for the current quarter points to revenue of 144.18 million US dollars, with estimated year-over-year growth of 12.60%, EBIT of 14.76 million US dollars with a 49.24% year-over-year increase, and EPS of 0.54 with a 57.50% year-over-year increase. Management’s margin trajectory implied by recent cadence suggests a gross margin profile near the mid-40% range and a net margin anchored around the mid–single digits; adjusted EPS is expected to grow faster than revenue given improved operating leverage.

The main business mix is centered on on-demand manufacturing: computer numerical control machining, injection molding, 3D printing, and sheet metal. The most promising segment appears to be computer numerical control machining with 63.25 million US dollars in revenue last quarter and double‑digit momentum, supported by resilient demand across prototyping and low-volume production.

Last Quarter Review

Last quarter, Proto Labs reported revenue of 139.34 million US dollars, a gross profit margin of 45.64%, net profit attributable to shareholders of 8.11 million US dollars with a net margin of 5.82%, and adjusted EPS of 0.54, with revenue up 10.41% year over year and adjusted EPS up 63.64% year over year. Quarter on quarter, net profit increased 35.21%, reflecting improved cost control and favorable mix.

A notable highlight was solid operating execution, with EBIT of 15.39 million US dollars, which exceeded market expectations. The main business contributed as follows: computer numerical control machining 63.25 million US dollars, injection molding 51.07 million US dollars, 3D printing 20.47 million US dollars, sheet metal 4.35 million US dollars, and other services 0.21 million US dollars.

Current Quarter Outlook

Main business: On-demand manufacturing platform breadth

Proto Labs’ core platform spans computer numerical control machining, injection molding, 3D printing, and sheet metal, serving rapid prototyping and low-volume production. With revenue expected to rise 12.60% year over year to 144.18 million US dollars, mix effects and ongoing pricing discipline are likely to sustain a gross margin profile around the mid‑40% level. The bridge from revenue to EPS benefits from a lean cost base and automation in quoting and manufacturing workflows, reinforcing incremental operating leverage. Cross‑sell across services can support order value, while short lead times remain a differentiator in cyclical demand.

Most promising business: Computer numerical control machining

Computer numerical control machining remains the largest revenue contributor at 63.25 million US dollars last quarter and is positioned to outgrow the aggregate portfolio on stable industrial demand for precision parts. The breadth of material options and tolerances, plus time-to-quote advantages, continue to attract engineering organizations balancing speed with manufacturability. As capacity utilization improves, this segment should provide disproportionate contribution to EBIT. The near-term watch item is pricing versus input costs, as machining hours and material costs can influence realized margins.

Key stock driver this quarter: Margin durability and EPS delivery

The key debate centers on whether Proto Labs can defend mid‑40% gross margins while expanding EBIT faster than revenue. The company’s forecast implies that EPS growth of 57.50% year over year outpaces the 12.60% revenue growth, suggesting operating leverage from productivity, mix, and disciplined spending. Execution on order intake in higher-value machining and resilient molded parts demand can support the thesis; any deceleration in high‑margin mix or cost inflation would weigh on conversion. Delivering on the 14.76 million US dollars EBIT estimate and sustaining net margin around the mid–single digits would validate the earnings traction.

Analyst Opinions

Cautiously positive commentary prevails among recent institutional notes, with a majority leaning bullish on near-term EPS resilience and operating leverage. Analysts highlight the improving conversion from revenue to EBIT and the continued strength in on-demand machining as primary supports for the current quarter’s setup. The constructive view emphasizes that backlog quality and mix should help Proto Labs meet or modestly exceed EPS estimates even if revenue lands near the midpoint, while the main risk cited is a potential slowdown in discretionary prototyping spend that could temper top-line growth.